Professional Documents
Culture Documents
CCN Nervous System
CCN Nervous System
REFERRED PAIN
o pain perceived as arising from a site that is different from its true point of origin
o the “true point of origin” is from visceral organ or deep somatic structure
o the “point of reference” is some area of the body surface
o the most generally accepted theory for referred pain is that the 2 sensory neurons, one
from the region of the true point of origin and one from the point of reference, enter
the same segment of the spinal cord and synapse with the same projection neuron
o Referring pain from SEVERE CARDIAC ISCHEMIA to the left arm or the
o referring of DIAPHRAGMATIC PAIN to the neck and shoulder
PATIENT ASSESSMENT
MENTAL STATUS
o Alert (full consciousness): normal
o Awake: fully oriented when aroused
o Lethargic: drowsy but follows simple commands when stimulated
o Obtunded (somnolent): arousable with stimulation; responds verbally with a word or
two; follows simple commands; otherwise, drowsy
o Stuporous: very hard to arouse; inconsistently may follow simple commands or speak
single words or short phrases; limited spontaneous movement
o Semi-comatose: movements are purposeful when stimulated; does not follow
commands or speak coherently
o Comatose: may respond with reflexive posturing when stimulated or may have no
response to any stimulus
Neuro Assessment:
1. Mental Status
o Assess orientation and memory
o Orientation involves people, time and lace
o Memory includes: short term, recent and remote memory
2. Level of Consciousness:
o is the single most sensitive indicator of changes in the neurologic status
- Level I: Conscious, coherent, cognitive
- Level II: Confused, drowsy, lethargic, somnolent, obtunded
- Level III: Stuporous (e.g. sternal pressure, trapezius pinch, pressure at the base
- of the nail, or supraorbital area; very strong or loud sound)
- Level IV:
- Light Coma: grimace or withdrawing limp from pain
- Deep Coma: absence of response to even the most painful stimuli
MOTOR FUNCTION
Motor responses to Pain
PUPILLARY CHANGES
PERRLA, Pupils Equal, Round, Reactive to Light and Accommodation
o in millimeter (mm)
o pupils size and shape
o Anisocoria
Pinpoint pupils: Drugs (opiates), Drops (meds for glaucoma), “Nearly dead” (damage in the
pons area of the brain stem)
Dilated Pupils: Fear (panic attack, extreme anxiety), “Fits” (seizure), “Fast
Living” (cocaine, crack, phencyclidine)
Finger to Nose Test
- is performed by having the patient touch one finger to the examiner’s finger, then
touch his or her own nose; assess coordination
- overshooting or past-pointing the mark is called DYSMETRIA.
- Both sides are tested individually
- FTNT (Foot to Nose Test), HKT (Head to Knee to Toe test), Heel to Shin Test
Pronator Drift
- have the patient hold the arms straight out with palms upward and eyes closed and
observe for any untoward drift or pronation of the forearms
Oculocephalic Reflex
- indicates an intact brainstem
- this maneuver must not be performed in a person with possible cervical spine injury
Romberg Test
- to assess cerebellar function (receives information from the sensory systems, the
spinal cord, and other parts of the brain and then regulates motor movements)
- done by asking the client to stand with the feet together & the eyes closed or
asked to walk in an imaginary line
- if the client falls or experiences uncoordinated movement (ataxia), this is positive
Romberg that indicates cerebellar function impairment
Apraxia - inability to perform fine (learned) motor activities like whistle, singing, smacking
Agraphia is inability to write
Ataxia - uncoordinated movement, characterized by wide – base stance and swaying manner
of walking
SENSATION
Proprioception is tested by asking the patient, with eyes closed to identify
the direction of the movement of finger in both extremities
Agnosia is the inability to recognize objects by touch, sight, or sound
Stereognosis is the ability to recognize and identify objects by touch
- is a function of the parietal lobe
Graphesthesia is the ability to recognize numbers or letters traced lightly on
the skin
VITAL SIGNS
Respirations:
Cheyne-Stokes respirations
- (Crescendo-decrescendo respirations alternating with periods of apnea)
Hypoventilation
- can lead to respiratory acidosis
Hyperventilation
- after cerebral trauma produces respiratory alkalosis with decreased blood CO2
levels
Shallow, rapid respirations
- can indicate a problem with maintenance of a patent airway or the need for
suctioning
Snoring respirations or stridor
- can indicate a partially obstructed airway
VITAL SIGNS
Temperature (hypothalamus)
HYPOTHERMIA
- occurs with metabolic causes, pituitary damage and spinal cord injuries
CNS
- fevers may be very high and differentiate themselves from other causes of fever by
their resistance to antipyretic therapy
Pulse –
- Tachycardia in increased ICP, alterations in ECG pattern such as atrial or ventricular
dysrhythmias
-
Blood Pressure (medulla)
Hypertension is common due to increase in ICP
Hypotension must be avoided in the post-injury stage because it can lead to decreased
cerebral perfusion, hypoxia and extension of the initial injury
CUSHING’S TRIAD
1. increased systolic pressure (resulting in an increased pulse pressure)
2. bradycardia
3. irregular respirations
4. pupillary changes - a sign of impending herniation
NEURODIAGNOSTIC STUDIES
Computed Tomography or CT scan (Invasive and Noninvasive)
- a scanner takes a series of radiographic images all around the same axial plane. A
computer hen creates a composite picture of various tissue densities visualized. The
images may be enhanced with the use of IV contrast dye
- Instruct the patient to lie flat on a table with the machine surrounding
❖ Patient must remain immobile as possible
Mannitol Administration –
- a hypertonic crystalloid solution that decerease
- cerebral edema, is also used as first-tier therapy for reducing ICP after brain injury
- monotherapy, if combined with Furosemide, there is a risk for excessive diuresis,
causing depletion of intravascular urine and electrolytes
- foley catheter must be inserted
- BP precaution
RESPIRATORY SUPPORT
- Normocapnia is essential for maintaining stable ICP because CO2 directly affects
the degree of vasodilation in the cerebral blood vessels
- limit the duration of passes of suction catheter to no more than 5-10 seconds avoids
hypoxia
- limiting the number of passes to 1 or 2 avoids overstimulation of the cough reflex
and decreases the incidence of intrathoracic pressure and ICP
PHARMACOLOGICAL THERAPY
Analgesics, Sedatives and Paralytics
In patients with severe brain injury, GCS Score < 8:
- reduce agitation, discomfort and pain
- facilitate mechanical ventilation by suppressing coughing
- limit responses to stimuli, such as suctioning
Analgesics – Opioid narcotics primarily affect the CNS
Fentanyl and morphine
- Limit pain caused by injuries and nursing interventions
- Facilitate mechanical ventilation
- Potentiate the effect of sedatives
- adverse effects: respiratory depression, depression of the cough reflex, mood
changes, nausea and vomiting
Naloxone (Narcan) reverses CNS depression (narco toxicity)
SEDATIVES
- Benzodiazepines
- Midazolam, Diazepam (Valium), Lorazepam before ICU procedures and as needed
to treat anxiety
- Lorazepam for alcohol withdrawal and anticonvulsant therapy
- Midazolam with Fentanyl is most often used before procedures
ANESTHETICS
- Propofol is administered as continuous infusion to decrease agitation in the
critically ill patient
- common side effect is Hypotension
BP Management
- MAP greater than 110 mm Hg must be avoided
- ACE inhibitors: Lisinopril
- B blockers:
SEIZURE PROPHYLAXIS
- 7 days use to decrease the incidence of early seizure
- Phenytoin, Levetiracetam and Carbamazepine (Tegretol)
- Levetiracetam is more convenient to administer as no blood drug levels need to be followed
HEADACHES
Migraine Headache
- caused by inflammation and dilatation of blood vessels in the brain.
- one side of the head is more affected than the other
- stress or life crisis
- last for hours to days. Pain is throbbing or pulsatile
- Aura of acute attacks includes visual field defects, confusion, paresthesia, paralysis
in extreme cases
- Associated symptoms are as follows: nausea and vomiting, chills, fatigue,
irritability, sweating, edema, photophobia, phonophobia (sound sensitivity)
Management:
- provide quiet environment, stress therapy and relaxation techniques
Diet: small, frequent meals
Avoid the ff: chocolate, nuts, onions, food seasoning, cheese, citrus fruits, coffee, pork, dairy
products, red wine
Pharma:
1. Beta-adrenergic blockers: Inderal (propranolol), Tenormin (Atenolol)
2. Calcium channel blockers: Calan (Verapamil)
3. Tricyclic antidepressants: Elavil (Amitriptyline)
4. Ergotamine tartrate
5. NSAIDS
6. Opioids: Demerol (Meperidine), Butorphanol nasal spray
7. Triptans (Selective Serotonin Receptor Agonists)
- Imtrex (Sumatriptan)
- Amerge (Naratriptan)
CLUSTER HEADACHE:
- episodes clustered together in quick succession for few days or weeks with
- remission that lasts for months
- intense, throbbing, deep and often unilateral
- begins in infraorbital and spread to head and neck
- it is precipitated by alcohol or nitrate
Associated symptoms: flushing, tearing of eyes, nasal stuffiness and swelling of temporal
vessels
Treatment includes narcotic analgesic during acute phase
TENSION HEADACHE:
- relate to tension and muscle contraction
- episodic and vary with stress
- usually bilateral, involves neck and shoulders
- associated symptoms includes sustained contraction of head and neck muscles
Treatment:
1. Non-narcotic analgesics: Acetaminophen, ASA
2. Elavil (Amitriptyline)
3. Relaxation techniques
NEUROLOGICAL DISORDERS
CEREBROVASCULAR DISEASE (STROKE)
Causes: Thrombosis, Embolism, Hemorrhage
- damage to a focal area of the brain
- occurs when there is a disruption of blood flow to a region of the brain
- “Brain attack”
Clinical Management
4 Goals:
1. Reperfusion
2. Prevention of recurrent thrombosis
3. Neuroprotection
4. Supportive care – emotional and behavioral modification, communication,
rehabilitation
STROKE
Thrombus or Embolus:
- oxygen and substrate deprivation of the cerebral tissue begins
Deprivation for 1 minute – reversible symptoms, such as LOC
O2 deprivation for longer periods – microscopic necrosis of the neurons (infarcted)
Clinical Manifestations:
• weakness,
• numbness,
• visual changes,
• dysarthria,
• dysphagia or aphasia
Transient Ischemic Attack (TIA)
- neurological deficit lasting less than 24 hours that is attributed to focal or retinal
ischemia
- if symptoms resolve in less than 24 hours
Thrombolytic Drugs
IV t-PA (streptokinase) –
- dissolves the clot and permits reperfusion of brain tissue
- should be initiated as quickly as possible; 4.5 hours or less from the onset of neuro
symptoms
- activates plasminogen
Anticoagulation
- dipyridamole, ticlopidine, clopidogrel (Plavix), aspirin (ASA)
- moderate consumption of leafy green vegetables containing vitamin K
- monitor prothrombin time and INR (bleeding); wof signs of bleeding
Surgical Management
• Carotid endarterectomy to prevent stroke
• Hemicraniectomy
• Extracranial-intracranial bypass surgery
Nonsurgical Management
• Carotid artery stenting
Emotional and Behavioral Modification
- controlling stimuli in the environment, providing rest periods, giving positive feedback,
providing repetition, reduce stress
Communication
Expressive or nonfluent dysphasia –
- patient understands language but is unable to use it appropriately; Left Broca’s area
(memory of motor patterns of speech is affected)
Receptive or fluent dysphasia –
- patient is unable to understand the meaning of the spoken word (and usually the
written word); left Wernicke’s area (control center for recognition of spoken language)
Global dysphasia –
- both expressive and receptive dysphasia
SEIZURES
SEIZURES
- is an episode of abnormal and excessive discharge of cerebral neurons
- it can result in altered sensory, motor or behavioral activities
- can be associated with changes in the LOC
- common sites are the frontal and temporal lobes, particularly the hippocampus in the
- medial temporal lobe
EPILEPSY –
- is a condition in which seizures are spontaneous and recurrent
STATUS EPILEPTICUS
- a condition of either continued seizure activity or repetitive seizures over a period of 30
minutes.
- Rapid succession and full consciousness is not regained between seizures
Etiology:
Idiopathic
- 50%,occur most often in children younger than 10 years of age Congenital and Genetic
causes – 10%
Causes: vascular disease, alcohol, cerebral tumors, trauma, infection or fever, metabolic
disturbances, anoxia, and degenerative diseases
Psychomotor seizure
- psychiatric component, aura is present (hallucinations or illusions)
- mental clouding (being out of touch of the environment), appears intoxicated
MANAGEMENT:
1. Stay with the patient
2. Protect the client from injury – padded siderails, no restraints, do not insert tongue
blade, ease patient on floor with pillow n head or place on lap
3. Promote patent airway
Diagnostic Tests:
• EEG, MRI, CT Scan
• Epilepsy monitoring unit
DRUG THERAPY:
• Carbamazepine (Tegretol)
• Gabapentin (Neurontin)
• Levitiracetam (Keppra)
• Phenobarbital – potential CNS toxicity; taper slowly
• Phenytoin (Dilantin) – dose guided by blood levels (10-20 mcg/ml); less expensive
a. parenteral DILANTIN should be diluted in normal saline
• Valproate (Depakote)
Etiology:
- half of patients have a mild febrile illness 2-3 weeks before the onset of symptoms
- respiratory or GI
- Campylobacter jejuni and cytomegalovirus are the causes of the most frequent
antecedent infections
Clinical Manifestations:
- flaccid, ascending paralysis develops quickly
- commonly affected in a symmetrical pattern
- starts as a weakness in the lower extremities
- may develop rapidly over the course of hours to days
- 3-4 weeks to develop
Acute stage: onset of symptoms and rapidly progresses until no additional deterioration
Plateau stage: symptomatic, days to weeks
Recovery Phase: can take up to 2 years; remyelination and axonal degeneration;
remyelination 1-2 mm/day
Clinical Management:
• ICU admission
• Mechanical Ventilation
• Preventive measures- PE, DVT (heparin)
• Intravenous immunoglobulin (IVIG) – adverse effect
is acute tubular necrosis
• Plasmapheresis – hemorrhage and catheter-related
infections
MYASTHENIA GRAVIS
MYASTHENIA GRAVIS
- is an autoimmune disorder of the neuromuscular junction transmission
- presents with fatigue and muscle weakness in the ocular, bulbar, diaphragm or limb
muscles
- derived from the Greek words for “muscle” and “weakness” whereas gravis means
“grave” in Latin
- because of the high mortality related to diaphragmatic muscle weakness, the disorder
was called “grave muscle weakness”
Pathophysiology:
- acetylcholine binds to the AChR
Epidemiology:
- seen more often in women than in men at a ratio of 3:2
Clinical Manifestations:
- Ocular Myasthenia or Generalized Myasthenia
Diagnosis:
Electromyography EMG - needle electrode is inserted in skeletal muscle; electrical activity
Blood is drawn for AChR antibodies
Tensilon Test (edrophonium)
- 10 mg IV Tensilon is given over 1 minute
- a response is anticipated within 2-3 minutes
- Atropine should be readily available in the event of bradycardia
Clinical Management:
• Long-term immunosuppression with corticosteroids
• Mycophenolate mofetil (CellCept)
• Azathioprine (Imuran) or cyclosporine
• Cyclophosphamide (Cytoxan)
• IVIG
• Plasmapheresis
• Thymectomy
Diagnosis:
Electromyography EMG
- needle electrode is inserted in skeletal muscle; electrical activity
- Blood is drawn for AChR antibodies
Tensilon Test (edrophonium)
- 10 mg IV Tensilon is given over 1 minute
- a response is anticipated within 2-3 minutes
- Atropine should be readily available in the event of bradycardia
Pharmacological Management:
Pyridostigmine (Mestinon)
- liquid, 60 mg tablet, 180 mg time-span formula or IV neostigmine
S/S of crisis
Avoid crowds – movies or concerts
Support groups – Myasthenia Gravis Foundation